UnitedHealth Group (NYSE: UNH) subsidiary Optum entered a new waiver agreement that has delayed the deadline to complete its $3.3 billion acquisition of Amedisys (Nasdaq: AMED). The agreement comes on the heels of an antitrust lawsuit that the U.S. Department of Justice (DOJ) filed last month to block the transaction due to concerns that it […]
Texas-based New Day Healthcare LLC has announced its acquisition of Good Samaritan Society’s hospice operations in its home state. The financial terms of the deal were undisclosed. The transaction includes Good Samaritan’s hospice assets in El Paso, Texas, expanding New Day’s existing presence in that market. The deal marks an important strategic move as New […]
Addus HomeCare Corporation (Nasdaq: ADUS) has closed its $350 million acquisition of Gentiva’s personal care business. Gentiva’s personal care segment brings in annual revenues of close to $280.0 million. Post-transaction, Addus will continue with a leverage ratio of less than 3x, with the ability to further that amount with the influx of revenue resulting from […]
Valuations in the hospice space have led Addus Homecare (Nasdaq: ADUS) to take a more conservative approach to hospice transactions as it actively seeks home health and personal care deals. Hospice multiples reach record highs in 2020 and 2021, as much as 26x. Since then the price tags have reportedly come down, but they haven’t […]
New Day Healthcare LLC is prioritizing hospice growth in its strategic plans as the home-based care company focuses on improving quality for patients across the care continuum. Texas-based New Day launched in 2020 by a group of former hospice and home health professionals. The organization offers hospice, home health and personal care through several brands. […]
The rationale behind the U.S. Justice Department’s lawsuit against Optum and Amedisys (Nasdaq: AMED) is multi-faceted, citing potential adverse impacts on competition, home-based care workers and payers. Optum, a subsidiary of UnitedHealth Group (NYSE: UNH) in June 2023 penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 […]
Quality, compliance and financial stability are top of mind in hospice merger and acquisitions (M&A) as this year comes to an end. Stakeholders are projecting a more frothy market in 2025, though regulatory concerns could sway buying decisions. Growing demand is among the constants driving investor interest in the hospice space, according to Tom Lillis, […]
As it considers potential acquisitions, VITAS Healthcare is focused on large assets in certificate of need (CON) states. VITAS is a subsidiary of Chemed Corp. (NYSE: CHE). The company this year made its return to the M&A market after a hiatus of several years. In April, VITAS acquired Covenant Health and Community Services’ hospice operations […]
The U.S. Department of Justice (DOJ) has filed an antitrust lawsuit to block the acquisition of Amedisys (Nasdaq: AMED) by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Bloomberg first reported the news. This comes on heels of a “last rights” meeting between the DOJ and the two companies to advocate for sealing the deal. Amedisys […]
Texas-based New Day Healthcare LLC on Monday announced its acquisition of Intrepid USA’s hospice operations in Missouri and in its home state. The transaction expands the home-based service provider’s existing presence in those markets. The deal includes Intrepid’s hospice assets in Joplin and Springfield, Missouri, as well as its locations in Beaumont, Texas. Financial terms were […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
